We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JRVR icon
1376
James River Group Holdings
JRVR
$199M
$60.2K ﹤0.01%
2,431
AZZ icon
1377
AZZ Inc
AZZ
$4.55B
$60.2K ﹤0.01%
1,475
EXTR icon
1378
Extreme Networks
EXTR
$3.2B
$60.2K ﹤0.01%
6,750
-1,224
-15% -$12.4K
IRBT
1379
DELISTED
iRobot
IRBT
$60.2K ﹤0.01%
1,638
SXI icon
1380
Standex International
SXI
$4B
$60.2K ﹤0.01%
710
ENTA icon
1381
Enanta Pharmaceuticals
ENTA
$393M
$60.2K ﹤0.01%
1,273
XPEL icon
1382
XPEL
XPEL
$1.35B
$60.2K ﹤0.01%
1,310
+175
+15% +$8.26K
PGTI
1383
DELISTED
PGT, Inc.
PGTI
$60.1K ﹤0.01%
3,614
ENVX icon
1384
Enovix
ENVX
$966M
$60.1K ﹤0.01%
+7,713
New +$72.5K
BATRK icon
1385
Atlanta Braves Holdings Series B
BATRK
$3.41B
$60.1K ﹤0.01%
2,505
CVI icon
1386
CVR Energy
CVI
$3.52B
$60K ﹤0.01%
1,792
+285
+19% +$9.1K
TMP icon
1387
Tompkins Financial
TMP
$1.44B
$60K ﹤0.01%
832
CRNX icon
1388
Crinetics Pharmaceuticals
CRNX
$8.96B
$59.5K ﹤0.01%
3,191
+429
+16% +$8.56K
NE icon
1389
Noble Corp
NE
$7.04B
$59.5K ﹤0.01%
+2,346
New +$77.2K
HSKA
1390
DELISTED
Heska Corp
HSKA
$59.4K ﹤0.01%
628
SNDX icon
1391
Syndax Pharmaceuticals
SNDX
$1.77B
$59.3K ﹤0.01%
3,081
GPOR icon
1392
Gulfport Energy Corp
GPOR
$3.01B
$59.2K ﹤0.01%
+744
New +$69K
CERS icon
1393
Cerus
CERS
$572M
$59K ﹤0.01%
11,162
KAMN
1394
DELISTED
Kaman Corp
KAMN
$59K ﹤0.01%
1,889
LPSN icon
1395
LivePerson
LPSN
$35.9M
$59K ﹤0.01%
278
ASIX icon
1396
AdvanSix
ASIX
$427M
$59K ﹤0.01%
1,764
AVID
1397
DELISTED
Avid Technology Inc
AVID
$58.8K ﹤0.01%
2,267
EAT icon
1398
Brinker International
EAT
$10.2B
$58.8K ﹤0.01%
2,669
SCHL icon
1399
Scholastic
SCHL
$784M
$58.7K ﹤0.01%
1,631
COMP icon
1400
Compass
COMP
$10.2B
$58.5K ﹤0.01%
+16,218
New +$88.7K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.